Valsartan and the kidney: Present and future

Journal of Cardiovascular Pharmacology

Volumn 33, Issue SUPPL. 1, 1999, Pages

  Mann, Johannes F E ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Klinikum Schwabing   (Germany)

Author keywords

Angiotensin; Converting enzyme inhibition; Nonpeptide antagonists for type 1 receptors of angiotensin II; Renal hypertension; Renoprotection; Valsartan

Indexed keywords

ANGIOTENSIN II ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VALSARTAN;

CONFERENCE PAPER; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; KIDNEY FAILURE; NATRIURESIS; PRIORITY JOURNAL; PROTEINURIA; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE;

EID: 0032910822     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199900001-00008     Document Type: Conference Paper

References (19)

1. Mann J. Angiotensin II Rezeptor Antagonisten. Deutsche Med Wochenschr 1996;121:568-72.
2. Ichikawa I. Will angtotensin II receptor antagonists be renoprotective in humans? Kidney Int 1996;50:684-92.
3. Kon V, Fogo A, Ichikawa I, Hellings AE, Bills T. Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition. Kidney Int 1993;44:545-50.
4. Komers R, Cooper ME. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins. Am J Physiol 1995;37:F588-94.
5. Doig JK, MacFadyen RJ, Sweet CS, Reid JL. Haemodynamic and renal responses to oral losartan potassium during salt depletion or salt repletion in normal human volunteers. J Cardiovasc Pharmacol 1995;25:511-7.
6. Veelken R, Hilgers KF, Stetter A, Siebert HG, Schmieder RE, Mann JF. Nerve-mediated antidiuresis and antinatriuresis after airjet stress is modulated by angiotensin II. Hypertension 1996;28: 825-32.
7. Baboolal K, Meyer TW. The effect of acute angiotensin II blockade on renal function in rats with reduced renal mass. Kidney Int 1994;46:980-5.
8. Xie MH, Liu FY, Wong PC, Timmermanns PB, Cogan MG. Proximal nephron and renal effects of DUP 753, a nonpeptide angiotensin II antagonist. Kidney Int 1990;38:473-9.
9. Burnier M, Hagman M, Nussberger J, et al. Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects. Hypertension 1995;25:602-9.
10. Burnier M, Rutschmann B, Nussberger J, et al. Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects. Hypertension 1993;22:339-47.
11. Hutchinson FN, Webster SK. Effect of ANG II receptor antagonist on albuminuria and renal function in passive Heymann nephritis. Am J Physiol 1992;32:F311-8.
12. Lafayette RA, Mayer G, Park SK, Meyer TK. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992;90:766-71.
13. Gansevoort RT, de Zeeuw D, de Jong PE. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 1994;45:861-7.
14. Maschio G, Alberti D, Janin G, et al. Effects of angiotensin-converting enzyme inhibition with benazepril on the progression of renal failure. N Engl J Med 1996;334:949-54.
15. Lewis EJ, Hunsicker LG, Bain RP. Captopril inhibits the progression of diabetic nephropathy. N Engl J Med 1993;329:1456-62.
16. Nakamura T, Takahashi T, Fukui M, et al. Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. J Am Soc Nephrol 1995;5:1492-7.
17. Tanaka R, Kon V, Yoshioka T, Ichikawa I, Fogo A. Angiotensin-converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int 1994;45:537-43.
18. Remuzzi A, Perico N, Amuchastegnui CS, et al. Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 1993;4:40-9.
19. Lacourciere Y, Brunner HR, Irwin I, et al. Effects of modulators of the renin-angiotensin-aldosterone system on cough. J Hypertens 1994;12:1387-93.